# Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

> **NCT07075523** · — · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 36 (estimated)

## Conditions studied

- CAR T-Cell Therapy

## Interventions

- **OTHER:** Brain magnetic resonance imaging, neurocognitive assessments, quality of life questionnaire, biomarkers

## Key facts

- **NCT ID:** NCT07075523
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-19
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075523, "Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07075523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*